Pyogenic granuloma (PG) is a benign tumor that is composed of an accumulation of inflammatory cells, such as macrophages and neutrophils. It is commonly found on the skin and mucous membranes and can range in size from a few millimeters to several centimeters. It is also referred to as a lobular capillary hemangioma or a granuloma pyogenicum. Although it is not a life-threatening condition, it can be unsightly and cause discomfort. The exact cause of PG is unknown, but it is thought to be related to a combination of factors, including trauma, hormones, and certain medications. Treatment options vary depending on the size and location of the tumor, but may include topical creams, cryotherapy, and surgical excision. In this article, we will discuss the causes, symptoms, diagnosis, and treatments of PG.
Pyogenic granuloma is a benign tumor composed of an accumulation of inflammatory cells, such as macrophages and neutrophils. It is commonly found on the skin and mucous membranes and can range in size from a few millimeters to several centimeters. It is also referred to as a lobular capillary hemangioma or a granuloma pyogenicum. PG typically presents as a red, raised, and often ulcerated nodule. It is usually painless, but can be itchy or tender. The tumor is typically found on the head, neck, and upper extremities, but can also occur on the trunk and lower extremities.
The exact cause of PG is unknown, but it is thought to be related to a combination of factors, including trauma, hormones, and certain medications. Trauma to the skin, such as a cut or scrape, can cause the skin to become inflamed, which can trigger the development of PG. Hormonal changes, such as those that occur during pregnancy, can also cause PG. This is thought to be due to the increased levels of estrogen and progesterone, which can cause the blood vessels to become more fragile and prone to injury. Certain medications, such as those used to treat acne, can also trigger the development of PG. These medications can cause inflammation and irritation of the skin, which can lead to the formation of PG.
The most common symptom of PG is a red, raised, and often ulcerated nodule. It is usually painless, but can be itchy or tender. The tumor is typically found on the head, neck, and upper extremities, but can also occur on the trunk and lower extremities.
The diagnosis of PG is typically made based on the appearance of the tumor. If the diagnosis is uncertain, a biopsy may be performed to confirm the diagnosis. During a biopsy, a sample of the tissue is taken and examined under a microscope.
Treatment options vary depending on the size and location of the tumor. Smaller tumors can often be treated with topical creams, such as corticosteroids. These creams can reduce inflammation and help to shrink the tumor. Cryotherapy, or the use of cold temperatures to destroy tissue, can also be used to treat PG. This is often used for larger tumors that are located on the face or other visible areas. In some cases, surgical excision may be necessary to remove the tumor. This is typically done under local anesthesia and the area is then closed with sutures.
Pyogenic granuloma is a benign tumor composed of an accumulation of inflammatory cells. The exact cause of PG is unknown, but it is thought to be related to a combination of factors, including trauma, hormones, and certain medications. Treatment options vary depending on the size and location of the tumor, but may include topical creams, cryotherapy, and surgical excision. It is important to seek medical attention if you notice any suspicious growths on your skin or mucous membranes.
1.
Major Shifts in Urothelial Cancer Care: Immunotherapy Redefines Standards
2.
Two medications might work better for breast cancers that are resistant to one.
3.
Living near St. Louis-area Coldwater Creek during childhood linked with higher risk of cancer from radiation
4.
Resection for Early Liver Cancer Tied to Improved Survival.
5.
Researchers publish action plan to address appendiceal cancer enigmas
1.
Management of Relapsed Synovial Sarcoma: Current Treatment Strategies and Emerging Therapies
2.
MASLD and Cancer Risk: Pathogenic Links and Clinical Implications Reviewed
3.
Claudin-18.2 in Gastric Cancer: Tumor-Stroma Crosstalk and Disease Progression
4.
Rare Malignant Ovarian Tumors: A Comprehensive Review for Clinicians
5.
The latest research on Thyroid Cancer: Symptoms, Diagnosis, and Treatment Options
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part V
2.
Efficient Management of First line ALK-rearranged NSCLC - Part III
3.
Updates on Standard V/S High Risk Myeloma Treatment- The Next Part
4.
Benefits of Treatment with CDK4/6 Inhibitors in HR+/HER2- aBC in Clinical Trials and the Real World
5.
An Intro to The Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- Advanced Breast Cancer Clinical Studies.
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation